Carcinoembryonic antigen levels, cytokeratin 19 fragment (CYFRA21-1), and other serologic indicators which were associated with DM in patients with NSCLC (31, 32) have not been included in this study due to missing data in the SEER program. This evidence concerns the gene KRT19 and non-small cell lung carcinoma.